TD Cowen Lowers P3 Health Partners (NASDAQ:PIII) Price Target to $0.25

P3 Health Partners (NASDAQ:PIII) had its price objective lowered by TD Cowen from $0.90 to $0.25 in a report published on Wednesday,Benzinga reports. TD Cowen currently has a hold rating on the stock.

P3 Health Partners Stock Performance

Shares of NASDAQ:PIII opened at $0.20 on Wednesday. The company has a market capitalization of $72.90 million, a price-to-earnings ratio of -0.24 and a beta of 1.15. The firm’s 50 day simple moving average is $0.38 and its 200 day simple moving average is $0.50. The company has a debt-to-equity ratio of 1.11, a current ratio of 0.53 and a quick ratio of 0.53. P3 Health Partners has a fifty-two week low of $0.19 and a fifty-two week high of $1.78.

Insiders Place Their Bets

In related news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of the company’s stock in a transaction on Wednesday, September 4th. The shares were purchased at an average cost of $0.49 per share, for a total transaction of $39,200.00. Following the acquisition, the insider now owns 76,625,438 shares of the company’s stock, valued at approximately $37,546,464.62. This represents a 0.10 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In the last three months, insiders have purchased 400,000 shares of company stock worth $205,600. Company insiders own 17.86% of the company’s stock.

Institutional Trading of P3 Health Partners

Several hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its holdings in shares of P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after purchasing an additional 73,000 shares during the last quarter. Sanders Morris Harris LLC grew its stake in shares of P3 Health Partners by 16.3% in the second quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after buying an additional 20,000 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after buying an additional 550,925 shares in the last quarter. Emfo LLC grew its stake in shares of P3 Health Partners by 39.8% in the second quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after buying an additional 406,418 shares in the last quarter. Finally, Armistice Capital LLC bought a new position in shares of P3 Health Partners in the second quarter valued at $3,557,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.